- ISIN DE000A11QVV0
- Country Deutschland
Latest Research
News Functions
Additional Functions
7 March 2024
Heidelberg Pharma AG
Original-Research: Heidelberg Pharma AG (von EQUITS GmbH): Kaufen
19 July 2023
Heidelberg Pharma AG
Original-Research: Heidelberg Pharma AG (von EQUITS GmbH): Kaufen
30 April 2020
Heidelberg Pharma AG
Original-Research: HEIDELBERG PHARMA AG (von EQUITS GmbH): Kaufen
27 January 2020
Heidelberg Pharma AG
Original-Research: HEIDELBERG PHARMA AG (von EQUITS GmbH): Kaufen
29 March 2018
Heidelberg Pharma AG
Original-Research: HEIDELBERG PHARMA AG (von EQUITS GmbH): Kaufen
19 May 2017
Heidelberg Pharma AG
Original-Research: WILEX AG (von EQUITS GmbH): Kaufen
Latest News
News Functions
Additional Functions
25 April 2024
Heidelberg Pharma AG
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
17 April 2024
Heidelberg Pharma AG
Heidelberg Pharma AG: Walter Miller, buy
5 April 2024
Heidelberg Pharma AG
Heidelberg Pharma to host R&D Webinar following novel data presented at AACR
27 March 2024
Heidelberg Pharma AG
Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
26 March 2024
Heidelberg Pharma AG
Heidelberg Pharma AG: Dr. Georg F. Baur, buy
25 March 2024
Heidelberg Pharma AG
Heidelberg Pharma announces financial figures and reports on successful business performance in 2023
Upcoming Events
Latest Reports
News Functions
Additional Functions
29 April 2024
Heidelberg Pharma AG
Q1 statement / Q1 financial report 2023/2024
25 April 2024
Heidelberg Pharma AG
Q1 Mitteilung / Q1 Finanzbericht 2023/2024
26 March 2024
Heidelberg Pharma AG
Annual financial report 2022/2023
Heidelberg Pharma AG
Jahresfinanzbericht 2022/2023
12 October 2023
Heidelberg Pharma AG
Q3 statement / Q3 financial report 2022/2023